Trait centric view

1. Trait name:	Calving ease
   Ontology terms:	VT:0002907

   302 genes are associated with this trait, with QTL/association found

   • AAGAB: Alpha and gamma adaptin binding protein
     evidenced by: QTL:44366;
   • ABCC1: ATP binding cassette subfamily C member 1
     evidenced by: QTL:52526;
   • ABCC9: ATP binding cassette subfamily C member 9
     evidenced by: QTL:41430; QTL:41431; QTL:41433; QTL:41435;
   • ABHD2: Abhydrolase domain containing 2, acylglycerol lipase
     evidenced by: QTL:51091; QTL:51097;
   • ACOXL: Acyl-CoA oxidase like
     evidenced by: QTL:45059; QTL:45070; QTL:45080;
   • ACSS3: Acyl-CoA synthetase short chain family member 3
     evidenced by: QTL:40773;
   • ACTE1: Actin epsilon 1
     evidenced by: QTL:53995; QTL:54005;
   • ADAM10: ADAM metallopeptidase domain 10
     evidenced by: QTL:44752;
   • ADAM2: ADAM metallopeptidase domain 2
     evidenced by: QTL:53537; QTL:53545;
   • ADAMTS17: ADAM metallopeptidase with thrombospondin type 1 motif 17
     evidenced by: QTL:50967; QTL:50980;
   • ADAMTS6: ADAM metallopeptidase with thrombospondin type 1 motif 6
     evidenced by: QTL:50605;
   • ADCY3: Adenylate cyclase 3
     evidenced by: QTL:45542; QTL:45556;
   • ADCY5: Adenylate cyclase 5
     evidenced by: QTL:38477; QTL:38480;
   • AKAP6: A-kinase anchoring protein 6
     evidenced by: QTL:51219; QTL:51225;
   • AKT3: AKT serine/threonine kinase 3
     evidenced by: QTL:48277;
   • ALDH5A1: Aldehyde dehydrogenase 5 family member A1
     evidenced by: QTL:52229; QTL:52238;
   • AMOT: Angiomotin
     evidenced by: QTL:54697;
   • ANGPT1: Angiopoietin 1
     evidenced by: QTL:47661; QTL:47667;
   • ANKFN1: Ankyrin repeat and fibronectin type III domain containing 1
     evidenced by: QTL:50005; QTL:50018;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42307; QTL:42324;
   • APBB2: Amyloid beta precursor protein binding family B member 2
     evidenced by: QTL:42042; QTL:42054;
   • APH1B: Aph-1 homolog B, gamma-secretase subunit
     evidenced by: QTL:44735;
   • APP: Amyloid beta precursor protein
     evidenced by: QTL:38159;
   • ARHGAP10: Rho GTPase activating protein 10
     evidenced by: QTL:48692;
   • ARHGAP22: Rho GTPase activating protein 22
     evidenced by: QTL:53849; QTL:53857;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43056; QTL:43068; QTL:43075; QTL:43087;
   • ARHGAP6: Rho GTPase activating protein 6
     evidenced by: QTL:55453; QTL:55467;
   • ARHGEF12: Rho guanine nucleotide exchange factor 12
     evidenced by: QTL:47857;
   • ARHGEF9: Cdc42 guanine nucleotide exchange factor 9
     evidenced by: QTL:54834; QTL:54840;
   • ARPIN: Actin related protein 2/3 complex inhibitor
     evidenced by: QTL:51109; QTL:51121;
   • ARSG: Arylsulfatase G
     evidenced by: QTL:50255;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53313; QTL:53327;
   • ATP1A3: ATPase Na+/K+ transporting subunit alpha 3
     evidenced by: QTL:49726; QTL:49738;
   • AURKA: Aurora kinase A
     evidenced by: QTL:47311; QTL:47322;
   • AZIN1: Antizyme inhibitor 1
     evidenced by: QTL:47677;
   • BDP1: B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB
     evidenced by: QTL:50520; QTL:50531;
   • BMP5: Bone morphogenetic protein 5
     evidenced by: QTL:51980;
   • BSND: Barttin CLCNK type accessory subunit beta
     evidenced by: QTL:40127; QTL:40133;
   • BTBD11: BTB domain containing 11
     evidenced by: QTL:41130;
   • BUB3: BUB3 mitotic checkpoint protein
     evidenced by: QTL:53060; QTL:53065;
   • BYSL: Bystin like
     evidenced by: QTL:126032; QTL:126036;
   • C18H19ORF47: Chromosome 18 C19orf47 homolog
     evidenced by: QTL:49658; QTL:49672;
   • C8B: Complement C8 beta chain
     evidenced by: QTL:40070;
   • CACHD1: Cache domain containing 1
     evidenced by: QTL:39964;
   • CACNA2D3: Calcium voltage-gated channel auxiliary subunit alpha2delta 3
     evidenced by: QTL:51802; QTL:51809;
   • CACNG5: Calcium voltage-gated channel auxiliary subunit gamma 5
     evidenced by: QTL:50268; QTL:50276;
   • CADPS2: Calcium dependent secretion activator 2
     evidenced by: QTL:40606; QTL:40613; QTL:40618; QTL:40630;
   • CAPN3: Calpain 3, (p94)
     evidenced by: QTL:44610;
   • CC2D1A: Coiled-coil and C2 domain containing 1A
     evidenced by: QTL:42718; QTL:42728;
   • CCDC141: Coiled-coil domain containing 141
     evidenced by: QTL:39054;
   • CCDC69: Coiled-coil domain containing 69
     evidenced by: QTL:43213; QTL:43221;
   • CCDC91: Coiled-coil domain containing 91
     evidenced by: QTL:41323; QTL:41338;
   • CEP70: Centrosomal protein 70
     evidenced by: QTL:38821; QTL:38830;
   • CERS5: Ceramide synthase 5
     evidenced by: QTL:40847;
   • CERS6: Ceramide synthase 6
     evidenced by: QTL:39101;
   • CFAP43: Cilia and flagella associated protein 43
     evidenced by: QTL:52824;
   • CHRM3: Cholinergic receptor muscarinic 3
     evidenced by: QTL:53741;
   • CNTN5: Contactin 5
     evidenced by: QTL:47778; QTL:47791;
   • COL12A1: Collagen type XII alpha 1 chain
     evidenced by: QTL:51954;
   • COL4A4: Collagen type IV alpha 4 chain
     evidenced by: QTL:39570; QTL:39581;
   • COL4A6: Collagen type IV alpha 6 chain
     evidenced by: QTL:54586; QTL:54600;
   • COL6A1: Collagen type VI alpha 1 chain
     evidenced by: QTL:38927; QTL:38937;
   • CPA5: Carboxypeptidase A5
     evidenced by: QTL:40657; QTL:40667;
   • CPEB3: Cytoplasmic polyadenylation element binding protein 3
     evidenced by: QTL:52664;
   • CPSF3: Cleavage and polyadenylation specific factor 3
     evidenced by: QTL:46015; QTL:46022;
   • CRTC1: CREB regulated transcription coactivator 1
     evidenced by: QTL:42634;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:40825; QTL:40836;
   • CSGALNACT1: Chondroitin sulfate N-acetylgalactosaminyltransferase 1
     evidenced by: QTL:53588; QTL:53598;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53757; QTL:53769;
   • CTU1: Cytosolic thiouridylase subunit 1
     evidenced by: QTL:146996; QTL:147006; QTL:147029; QTL:147039;
   • CUL2: Cullin 2
     evidenced by: QTL:46808; QTL:46820;
   • CUL3: Cullin 3
     evidenced by: QTL:39549;
   • DAB1: DAB adaptor protein 1
     evidenced by: QTL:40056; QTL:40061;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46320; QTL:46335;
   • DCUN1D1: Defective in cullin neddylation 1 domain containing 1
     evidenced by: QTL:38488; QTL:38500;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:3518;
   • DHX32: DEAH-box helicase 32 (putative)
     evidenced by: QTL:53088; QTL:53100;
   • DICER1: Dicer 1, ribonuclease III
     evidenced by: QTL:126030;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:53107; QTL:53121;
   • DOCK5: Dedicator of cytokinesis 5
     evidenced by: QTL:43692;
   • DOK6: Docking protein 6
     evidenced by: QTL:52290;
   • DOT1L: DOT1 like histone lysine methyltransferase
     evidenced by: QTL:42858;
   • DSCAM: DS cell adhesion molecule
     evidenced by: QTL:38917; QTL:38924;
   • DTNA: Dystrobrevin alpha
     evidenced by: QTL:52353; QTL:52360;
   • EBF1: EBF transcription factor 1
     evidenced by: QTL:43243; QTL:43255;
   • EED: Embryonic ectoderm development
     evidenced by: QTL:126040;
   • EGF: Epidermal growth factor
     evidenced by: QTL:41919; QTL:41932;
   • EIF2B3: Eukaryotic translation initiation factor 2B subunit gamma
     evidenced by: QTL:40184; QTL:40193;
   • ENTHD1: ENTH domain containing 1
     evidenced by: QTL:41611;
   • EPB41L2: Erythrocyte membrane protein band 4.1 like 2
     evidenced by: QTL:44092; QTL:44104;
   • EPHB1: EPH receptor B1
     evidenced by: QTL:38836; QTL:38843; QTL:38847; QTL:38855; QTL:38859; QTL:38865;
   • ESR1: Estrogen receptor 1
     evidenced by: QTL:44271;
   • ESRRG: Estrogen related receptor gamma
     evidenced by: QTL:48170; QTL:48175;
   • EXOC4: Exocyst complex component 4
     evidenced by: QTL:40671; QTL:40679;
   • EXT1: Exostosin glycosyltransferase 1
     evidenced by: QTL:47624;
   • EZR: Exrin
     evidenced by: QTL:126035;
   • FA2H: Fatty acid 2-hydroxylase
     evidenced by: QTL:49434; QTL:49447;
   • FAM134B: Family with sequence similarity 134 member B
     evidenced by: QTL:50916;
   • FAT3: FAT atypical cadherin 3
     evidenced by: QTL:53883; QTL:53894;
   • FBLN5: Fibulin 5
     evidenced by: QTL:51385; QTL:51400;
   • FCHO1: FCH and mu domain containing endocytic adaptor 1
     evidenced by: QTL:42668;
   • FER1L5: Fer-1 like family member 5
     evidenced by: QTL:45090;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51685; QTL:51698; QTL:51704; QTL:51712; QTL:51727; QTL:51731; QTL:51742;
   • FLT4: Fms related receptor tyrosine kinase 4
     evidenced by: QTL:42615; QTL:42627;
   • FNDC3B: Fibronectin type III domain containing 3B
     evidenced by: QTL:38633; QTL:38641;
   • FRMD5: FERM domain containing 5
     evidenced by: QTL:51339; QTL:51353; QTL:51358; QTL:51367;
   • FRMD6: FERM domain containing 6
     evidenced by: QTL:44725;
   • FRYL: FRY like transcription coactivator
     evidenced by: QTL:42059;
   • FUT10: Fucosyltransferase 10
     evidenced by: QTL:53463; QTL:53472;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:41516; QTL:41526;
   • GADL1: Glutamate decarboxylase like 1
     evidenced by: QTL:51533; QTL:51536; QTL:51537; QTL:51540;
   • GARIN2: Golgi associated RAB2 interactor family member 2
     evidenced by: QTL:44952; QTL:44954;
   • GML: Glycosylphosphatidylinositol anchored molecule like
     evidenced by: QTL:47439;
   • GNAS: GNAS complex locus
     evidenced by: QTL:16133; QTL:16134; QTL:16140; QTL:16141;
   • GOLT1A: Golgi transport 1A
     evidenced by: QTL:48053;
   • GPHN: Gephyrin
     evidenced by: QTL:44948;
   • GPM6B: Glycoprotein M6B
     evidenced by: QTL:55435; QTL:55448;
   • GRIA3: Glutamate ionotropic receptor AMPA type subunit 3
     evidenced by: QTL:54162; QTL:54196;
   • GRIK2: Glutamate ionotropic receptor kainate type subunit 2
     evidenced by: QTL:43995; QTL:44004;
   • GSK3A: Glycogen synthase kinase 3 alpha
     evidenced by: QTL:49677; QTL:49692;
   • GSTO2: Glutathione S-transferase omega 2
     evidenced by: QTL:52839; QTL:52849;
   • GTDC1: Glycosyltransferase like domain containing 1
     evidenced by: QTL:39431; QTL:39436;
   • HHAT: Hedgehog acyltransferase
     evidenced by: QTL:48479; QTL:48489;
   • HPCAL1: Hippocalcin like 1
     evidenced by: QTL:45972; QTL:45983;
   • HPSE2: Heparanase 2 (inactive)
     evidenced by: QTL:52747; QTL:52757; QTL:52769; QTL:52782;
   • HSD17B12: Hydroxysteroid (17-beta) dehydrogenase 12
     evidenced by: QTL:47970;
   • HSD17B14: Hydroxysteroid 17-beta dehydrogenase 14
     evidenced by: QTL:49845; QTL:49857;
   • IGSF5: Immunoglobulin superfamily member 5
     evidenced by: QTL:38905; QTL:38913;
   • IL1RAPL2: Interleukin 1 receptor accessory protein-like 2
     evidenced by: QTL:54530; QTL:54542;
   • ITGB1BP1: Integrin subunit beta 1 binding protein 1
     evidenced by: QTL:46026; QTL:46036;
   • ITPK1: Inositol-tetrakisphosphate 1-kinase
     evidenced by: QTL:51417; QTL:51432;
   • JAK1: Janus kinase 1
     evidenced by: QTL:39915; QTL:39927; QTL:39935; QTL:39948;
   • KCNC3: Potassium voltage-gated channel subfamily C member 3
     evidenced by: QTL:147000; QTL:147033;
   • KCNIP1: Potassium voltage-gated channel interacting protein 1
     evidenced by: QTL:50352;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:41963; QTL:41975;
   • KDM4C: Lysine demethylase 4C
     evidenced by: QTL:43615; QTL:43622; QTL:43624; QTL:43631; QTL:43633;
   • KDM6A: Lysine demethylase 6A
     evidenced by: QTL:54878;
   • KHDRBS2: KH RNA binding domain containing, signal transduction associated 2
     evidenced by: QTL:51867; QTL:51877;
   • KIF26B: Kinesin family member 26B
     evidenced by: QTL:48262;
   • KLHL1: Kelch like family member 1
     evidenced by: QTL:46309; QTL:46317;
   • KMT2A: Lysine methyltransferase 2A
     evidenced by: QTL:47837; QTL:47847;
   • LAP3: Leucine aminopeptidase 3
     evidenced by: QTL:25195; QTL:25207; QTL:25208; QTL:25209; QTL:25210; QTL:25211; QTL:25212; QTL:25213;
   • LCORL: Ligand dependent nuclear receptor corepressor-like
     evidenced by: QTL:25198; QTL:25199; QTL:25200; QTL:25201; QTL:25216;
   • LDLRAD4: Low density lipoprotein receptor class A domain containing 4
     evidenced by: QTL:126037;
   • LEP: Leptin
     evidenced by: QTL:13012; QTL:13013; QTL:13014;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42551;
   • LIPT2: Lipoyl(octanoyl) transferase 2
     evidenced by: QTL:47919;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:42206; QTL:42213;
   • LOC788895: RCG24645-like
     evidenced by: QTL:4642;
   • LRBA: LPS responsive beige-like anchor protein
     evidenced by: QTL:48670; QTL:48681;
   • LRFN2: Leucine rich repeat and fibronectin type III domain containing 2
     evidenced by: QTL:52045;
   • MACROD2: MACRO domain containing 2
     evidenced by: QTL:43702;
   • MAML3: Mastermind like transcriptional coactivator 3
     evidenced by: QTL:48970; QTL:48981;
   • MAN2A1: Mannosidase alpha class 2A member 1
     evidenced by: QTL:126034;
   • MAOB: Monoamine oxidase B
     evidenced by: QTL:54912; QTL:54924;
   • MBNL3: Muscleblind like splicing regulator 3
     evidenced by: QTL:54323;
   • MCM8: Minichromosome maintenance 8 homologous recombination repair factor
     evidenced by: QTL:47133;
   • MCUB: Mitochondrial calcium uniporter dominant negative subunit beta
     evidenced by: QTL:41937; QTL:41947;
   • MDM1: Mdm1 nuclear protein
     evidenced by: QTL:40919;
   • MEF2C: Myocyte enhancer factor 2C
     evidenced by: QTL:43357;
   • MFGE8: Milk fat globule-EGF factor 8 protein
     evidenced by: QTL:51080; QTL:51087;
   • MGMT: O-6-methylguanine-DNA methyltransferase
     evidenced by: QTL:53250; QTL:53262;
   • MGP: Matrix Gla protein
     evidenced by: QTL:41512;
   • MINAR2: Membrane integral NOTCH2 associated receptor 2
     evidenced by: QTL:42890; QTL:42896;
   • MLXIP: MLX interacting protein
     evidenced by: QTL:49342; QTL:49347;
   • MND1: Meiotic nuclear divisions 1
     evidenced by: QTL:48579; QTL:48586;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:52004; QTL:52013;
   • MSN: Moesin
     evidenced by: QTL:54823; QTL:54830;
   • MSTN: Myostatin
     evidenced by: QTL:11632;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40980;
   • MYH14: Myosin heavy chain 14
     evidenced by: QTL:146999; QTL:147032;
   • NALCN: Sodium leak channel, non-selective
     evidenced by: QTL:46542;
   • NBAS: NBAS subunit of NRZ tethering complex
     evidenced by: QTL:38375; QTL:45732; QTL:45736; QTL:45749;
   • NCAPG: Non-SMC condensin I complex, subunit G
     evidenced by: QTL:25214; QTL:25215;
   • NCOA1: Nuclear receptor coactivator 1
     evidenced by: QTL:45570;
   • NCSTN: Nicastrin
     evidenced by: QTL:39711; QTL:39723;
   • NDP: Norrin cystine knot growth factor NDP
     evidenced by: QTL:54901; QTL:54908;
   • NDUFAF1: NADH:ubiquinone oxidoreductase complex assembly factor 1
     evidenced by: QTL:44514; QTL:44520;
   • NELFA: Negative elongation factor complex member A
     evidenced by: QTL:42590;
   • NFAM1: NFAT activating protein with ITAM motif 1
     evidenced by: QTL:41671; QTL:41683;
   • NFIX: Nuclear factor I X
     evidenced by: QTL:42758; QTL:42771;
   • NHSL1: NHS like 1
     evidenced by: QTL:44136; QTL:44146;
   • NOX4: NADPH oxidase 4
     evidenced by: QTL:53913; QTL:53919;
   • NRF1: Nuclear respiratory factor 1
     evidenced by: QTL:40647; QTL:40653;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53812; QTL:53817; QTL:53829;
   • NRP1: Neuropilin 1
     evidenced by: QTL:46885;
   • NRSN2: Neurensin 2
     evidenced by: QTL:47333;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42571;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:41045; QTL:41061;
   • NT5E: 5'-nucleotidase, ecto (CD73)
     evidenced by: QTL:44075;
   • OSR1: Odd-skipped related transcription factor 1
     evidenced by: QTL:45624;
   • PACSIN1: Protein kinase C and casein kinase substrate in neurons 1
     evidenced by: QTL:51999;
   • PAH: Phenylalanine hydroxylase
     evidenced by: QTL:41012; QTL:41022;
   • PAPPA: Pregnancy-associated plasma protein A, pappalysin 1
     evidenced by: QTL:126027;
   • PARD3: Par-3 family cell polarity regulator
     evidenced by: QTL:46823; QTL:46834; QTL:46837; QTL:46850; QTL:46854; QTL:46865; QTL:46869; QTL:46881;
   • PCBD1: Pterin-4 alpha-carbinolamine dehydratase 1
     evidenced by: QTL:53773; QTL:53787;
   • PCDHA13: Protocadherin alpha 13
     evidenced by: QTL:43042; QTL:43052;
   • PCIF1: Phosphorylated CTD interacting factor 1
     evidenced by: QTL:47368; QTL:47377;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:40806; QTL:40817;
   • PDE4D: Phosphodiesterase 4D
     evidenced by: QTL:50688; QTL:50701; QTL:50707; QTL:50721;
   • PDGFRB: Platelet derived growth factor receptor beta
     evidenced by: QTL:43174; QTL:43184;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39726; QTL:39738;
   • PGF: Placental growth factor
     evidenced by: QTL:125750; QTL:125752; QTL:125754; QTL:125756; QTL:125758; QTL:125760; QTL:125762; QTL:125764; QTL:125766; QTL:125768; QTL:125770; QTL:125772;
   • PHACTR1: Phosphatase and actin regulator 1
     evidenced by: QTL:1633;
   • PHF20: PHD finger protein 20
     evidenced by: QTL:47342;
   • PHF2: PHD finger protein 2
     evidenced by: QTL:43714; QTL:43725;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55211; QTL:55225;
   • PIBF1: Progesterone immunomodulatory binding factor 1
     evidenced by: QTL:46362;
   • PIGN: Phosphatidylinositol glycan anchor biosynthesis class N
     evidenced by: QTL:52446;
   • PLA2G4F: Phospholipase A2 group IVF
     evidenced by: QTL:44566;
   • PLCB1: Phospholipase C beta 1
     evidenced by: QTL:46606; QTL:46619;
   • PLCH1: Phospholipase C eta 1
     evidenced by: QTL:38684;
   • PMP22: Peripheral myelin protein 22
     evidenced by: QTL:49963; QTL:49976;
   • PPA1: Pyrophosphatase (inorganic) 1
     evidenced by: QTL:126039;
   • PRICKLE1: Prickle planar cell polarity protein 1
     evidenced by: QTL:40879;
   • PRKD1: Protein kinase D1
     evidenced by: QTL:51179; QTL:51192; QTL:51206;
   • PRLHR: Prolactin releasing hormone receptor
     evidenced by: QTL:52906; QTL:52917;
   • PTBP2: Polypyrimidine tract binding protein 2
     evidenced by: QTL:39788;
   • RAD51: RAD51 recombinase
     evidenced by: QTL:44475;
   • RASGRP3: RAS guanyl releasing protein 3
     evidenced by: QTL:45179; QTL:45187;
   • RBM47: RNA binding motif protein 47
     evidenced by: QTL:42032; QTL:42040;
   • RBMS3: RNA binding motif single stranded interacting protein 3
     evidenced by: QTL:51527; QTL:51532;
   • RCAN2: Regulator of calcineurin 2
     evidenced by: QTL:52123;
   • REN: Renin
     evidenced by: QTL:48037;
   • RFX4: Regulatory factor X4
     evidenced by: QTL:41093; QTL:41106;
   • RMND5B: Required for meiotic nuclear division 5 homolog B
     evidenced by: QTL:42992;
   • RNF10: Ring finger protein 10
     evidenced by: QTL:49405;
   • ROCK2: Rho associated coiled-coil containing protein kinase 2
     evidenced by: QTL:45903; QTL:45915; QTL:45925;
   • ROR1: Receptor tyrosine kinase like orphan receptor 1
     evidenced by: QTL:39968; QTL:39977; QTL:39986; QTL:39991;
   • RPS6KC1: Ribosomal protein S6 kinase C1
     evidenced by: QTL:48463; QTL:48469;
   • RSPO2: R-spondin 2
     evidenced by: QTL:47650;
   • RTF1: RTF1 homolog, Paf1/RNA polymerase II complex component
     evidenced by: QTL:44524; QTL:44530;
   • RUNX1: RUNX family transcription factor 1
     evidenced by: QTL:38954; QTL:38962;
   • SART3: Spliceosome associated factor 3, U4/U6 recycling protein
     evidenced by: QTL:49412;
   • SEC22A: SEC22 homolog A, vesicle trafficking protein
     evidenced by: QTL:38458; QTL:38467; QTL:38469; QTL:38476;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41844; QTL:41860;
   • SEC63: SEC63 homolog, protein translocation regulator
     evidenced by: QTL:43960; QTL:43974;
   • SECISBP2: SECIS binding protein 2
     evidenced by: QTL:43751; QTL:43758;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52451; QTL:52464;
   • SFXN4: Sideroflexin 4
     evidenced by: QTL:52970; QTL:52985;
   • SH2D2A: SH2 domain containing 2A
     evidenced by: QTL:39742;
   • SHANK2: SH3 and multiple ankyrin repeat domains 2
     evidenced by: QTL:53970; QTL:53980;
   • SHROOM2: Shroom family member 2
     evidenced by: QTL:55628; QTL:55641;
   • SLC10A7: Solute carrier family 10 member 7
     evidenced by: QTL:48705; QTL:48717;
   • SLC16A7: Solute carrier family 16 member 7
     evidenced by: QTL:40940; QTL:40945;
   • SLC24A4: Solute carrier family 24 member 4
     evidenced by: QTL:51406; QTL:51411;
   • SLC25A12: Solute carrier family 25 member 12
     evidenced by: QTL:39074; QTL:39086;
   • SLC25A21: Solute carrier family 25 member 21
     evidenced by: QTL:51291;
   • SLC35D2: Solute carrier family 35 member D2
     evidenced by: QTL:43705; QTL:43711;
   • SLC39A10: Solute carrier family 39 member 10
     evidenced by: QTL:39470; QTL:39479;
   • SLC8A1: Solute carrier family 8 (sodium/calcium exchanger), member 1
     evidenced by: QTL:126028; QTL:45247; QTL:45248; QTL:45256;
   • SLC8A3: Solute carrier family 8 member A3
     evidenced by: QTL:44965;
   • SLCO1A2: Solute carrier organic anion transporter family member 1A2
     evidenced by: QTL:41440; QTL:41455;
   • SLIT3: Slit guidance ligand 3
     evidenced by: QTL:50310; QTL:50324; QTL:50332;
   • SMARCA5: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5
     evidenced by: QTL:48837;
   • SMOC1: SPARC related modular calcium binding 1
     evidenced by: QTL:44961;
   • SOWAHB: Sosondowah ankyrin repeat domain family member B
     evidenced by: QTL:42355; QTL:42367;
   • SPATA3: Spermatogenesis associated 3
     evidenced by: QTL:39599; QTL:39613;
   • SPATA45: Spermatogenesis associated 45
     evidenced by: QTL:48474;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43005; QTL:43019; QTL:43025; QTL:43035;
   • SREBF2: Sterol regulatory element binding transcription factor 2
     evidenced by: QTL:41613; QTL:41626;
   • SUN2: Sad1 and UNC84 domain containing 2
     evidenced by: QTL:41566; QTL:41580;
   • SUSD4: Sushi domain containing 4
     evidenced by: QTL:48258;
   • SYN2: Synapsin II
     evidenced by: QTL:51855;
   • SYN3: Synapsin III
     evidenced by: QTL:41178; QTL:41195; QTL:41211; QTL:41216; QTL:41229;
   • SYT3: Synaptotagmin 3
     evidenced by: QTL:126029; QTL:49876;
   • SYTL5: Synaptotagmin like 5
     evidenced by: QTL:54985;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39338; QTL:39350;
   • TASP1: Taspase 1
     evidenced by: QTL:46758;
   • TBC1D12: TBC1 domain family member 12
     evidenced by: QTL:52681; QTL:52691;
   • TBC1D9: TBC1 domain family member 9
     evidenced by: QTL:48957; QTL:48968;
   • TBCD: Tubulin folding cofactor D
     evidenced by: QTL:50070;
   • TCF20: Transcription factor 20
     evidenced by: QTL:41660; QTL:41668;
   • TENM2: Teneurin transmembrane protein 2
     evidenced by: QTL:43302; QTL:43311;
   • TGM7: Transglutaminase 7
     evidenced by: QTL:51299; QTL:51306;
   • TLR4: Toll-like receptor 4
     evidenced by: QTL:314697;
   • TM9SF2: Transmembrane 9 superfamily member 2
     evidenced by: QTL:46519; QTL:46526;
   • TMEM61: Transmembrane protein 61
     evidenced by: QTL:40141;
   • TPCN1: Two pore segment channel 1
     evidenced by: QTL:49394;
   • TRABD2B: TraB domain containing 2B
     evidenced by: QTL:40164; QTL:40170;
   • TRAPPC9: Trafficking protein particle complex 9
     evidenced by: QTL:47477; QTL:47489;
   • TRIM68: Tripartite motif containing 68
     evidenced by: QTL:47902;
   • UBE2E2: Ubiquitin conjugating enzyme E2 E2
     evidenced by: QTL:53600; QTL:53611;
   • UGT2A1: UDP glucuronosyltransferase family 2 member A1 complex locus
     evidenced by: QTL:42216; QTL:42224;
   • UNC5D: Unc-5 netrin receptor D
     evidenced by: QTL:53507;
   • USP13: Ubiquitin specific peptidase 13
     evidenced by: QTL:38582;
   • VIT: Vitrin
     evidenced by: QTL:45220;
   • VWA8: Von Willebrand factor A domain containing 8
     evidenced by: QTL:46191; QTL:46200;
   • WDFY3: WD repeat and FYVE domain containing 3
     evidenced by: QTL:42469; QTL:42473; QTL:42476;
   • WDR17: WD repeat domain 17
     evidenced by: QTL:53300; QTL:53311;
   • WWC3: WWC family member 3
     evidenced by: QTL:55585; QTL:55603;
   • XPO5: Exportin 5
     evidenced by: QTL:52095; QTL:52102;
   • ZBP1: Z-DNA binding protein 1
     evidenced by: QTL:47307;
   • ZBTB39: Zinc finger and BTB domain containing 39
     evidenced by: QTL:40963; QTL:40974;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:52173; QTL:52185;
   • ZNF280C: Zinc finger protein 280C
     evidenced by: QTL:54297; QTL:54302;
   • ZNF335: Zinc finger protein 335
     evidenced by: QTL:47382; QTL:47391;
   • ZNF404: Zinc finger protein 404
     evidenced by: QTL:49772; QTL:49785;
   • ZNF407: Zinc finger protein 407
     evidenced by: QTL:52262; QTL:52273;
   • ZNF45: Zinc finger protein 45
     evidenced by: QTL:49790; QTL:49802;
   • ZNF592: Zinc finger protein 592
     evidenced by: QTL:51133; QTL:51144;
   • ZNF891: Zinc finger protein 891
     evidenced by: QTL:49226;
   55 correlations are found involving Calving ease